A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors
Clinical trial NCT05267899 · UNKNOWN
Trial details
- NCT number
- NCT05267899
- Sponsor
- Zhejiang Haichang Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-10-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.